ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
Mei Pharma, Inc. (MM)

Mei Pharma, Inc. (MM) (MSHL)

0,4211
0,00
(0,00%)
Fermé 07 Février 10:00PM
0,4211
0,00
( 0,00% )
Avant marché: 1:00AM

Votre Hub pour des idées et discussions en direct en temps réel

Statistiques et détails clés

Dernier
0,4211
Prix Achat
0,00
Prix Vente
0,00
Volume échangé
-
0,00 Fourchette du Jour 0,00
0,00 Plage de 52 semaines 0,00
Clôture Veille
0,4211
Ouverture
-
Dernière Transaction
Dernière heure de transaction
-
Volume moyen (3 m)
-
Volume financier
-
VWAP
-

MSHL Dernières nouvelles

Marshall Edwards Announces Name Change to MEI Pharma ("MEIP")

Marshall Edwards Announces Name Change to MEI Pharma ("MEIP") New Name and Ticker Symbol Effective Monday, July 2, 2012 PR Newswire SAN DIEGO, June 28, 2012 SAN DIEGO, June 28, 2012 /PRNewswire/...

Marshall Edwards Presents Results From Clinical Trial Of Lead Oncology Drug Candidate ME-143

Marshall Edwards Presents Results From Clinical Trial Of Lead Oncology Drug Candidate ME-143 Data Presented at the American Society of Clinical Oncology Annual Meeting PR Newswire SAN DIEGO, June...

Marshall Edwards Announces First Cohort Of Patients Dosed In Phase I Clinical Trial Of Oncology Drug Candidate ME-344

Marshall Edwards Announces First Cohort Of Patients Dosed In Phase I Clinical Trial Of Oncology Drug Candidate ME-344 PR Newswire SAN DIEGO, May 29, 2012 SAN DIEGO, May 29, 2012 /PRNewswire/...

Marshall Edwards Completes Rights Offering To Stockholders

Marshall Edwards Completes Rights Offering To Stockholders PR Newswire SAN DIEGO, May 14, 2012 SAN DIEGO, May 14, 2012 /PRNewswire/ -- Marshall Edwards, Inc. (Nasdaq: MSHL), an oncology company...

Marshall Edwards Receives $4 Million Subscription From Novogen In Rights Offering

Marshall Edwards Receives $4 Million Subscription From Novogen In Rights Offering PR Newswire SAN DIEGO, May 8, 2012 SAN DIEGO, May 8, 2012 /PRNewswire/ -- Marshall Edwards, Inc. (Nasdaq:...

Marshall Edwards Issued New Patent For Use Of Lead Drug Candidate ME-143 In Treating Cancer

Marshall Edwards Issued New Patent For Use Of Lead Drug Candidate ME-143 In Treating Cancer Company Also Announces Two Japanese Patents Covering Lead Drug Candidates PR Newswire SAN DIEGO, April...

Marshall Edwards Receives FDA Approval of Investigational New Drug Application for Clinical Testing of Oncology Drug Candidat...

Marshall Edwards Receives FDA Approval of Investigational New Drug Application for Clinical Testing of Oncology Drug Candidate ME-344 PR Newswire SAN DIEGO, April 10, 2012 SAN DIEGO, April 10...

Marshall Edwards Announces Data from Clinical Trial of ME-143 Selected for Presentation at ASCO Annual Meeting

Marshall Edwards Announces Data from Clinical Trial of ME-143 Selected for Presentation at ASCO Annual Meeting PR Newswire SAN DIEGO, April 3, 2012 SAN DIEGO, April 3, 2012 /PRNewswire/...

Marshall Edwards CEO to Present at Needham Healthcare Conference

Marshall Edwards CEO to Present at Needham Healthcare Conference Live Webcast from New York on Wednesday, April 4 PR Newswire SAN DIEGO, March 28, 2012 SAN DIEGO, March 28, 2012 /PRNewswire/...

Marshall Edwards Receives Notice of Effectiveness for Rights Offering to Stockholders

Marshall Edwards Receives Notice of Effectiveness for Rights Offering to Stockholders PR Newswire SAN DIEGO, March 27, 2012 SAN DIEGO, March 27, 2012 /PRNewswire/ -- Marshall Edwards, Inc...

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

MSHL - Frequently Asked Questions (FAQ)

What is the current Marshall Edwards share price?
The current share price of Marshall Edwards is US$ 0,4211
What is the 1 year trading range for Marshall Edwards share price?
Marshall Edwards has traded in the range of US$ 0,00 to US$ 0,00 during the past year

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
MGOLMGO Global Inc
US$ 0,3875
(109,46%)
87,33M
UPCUniverse Pharmaceuticals Inc
US$ 0,2988
(85,59%)
69,93M
RANDRand Capital Corporation
US$ 36,74
(59,67%)
7
ZOOZZOOZ Power Ltd
US$ 3,22
(56,31%)
46
LCNBLCNB Corporation
US$ 23,99
(53,00%)
7
BTMDBiote Corporation
US$ 2,07
(-56,96%)
43
ANIKAnika Therapeutics Inc
US$ 8,00
(-55,03%)
20
EDRYEuroDry Ltd
US$ 6,01
(-45,01%)
4
PFCPremier Financial Corporation
US$ 17,01
(-39,89%)
5
NKLANikola Corporation
US$ 0,461
(-38,74%)
1,95M
MGOLMGO Global Inc
US$ 0,3875
(109,46%)
87,33M
UPCUniverse Pharmaceuticals Inc
US$ 0,2988
(85,59%)
69,93M
NIVFNewGenIvf Group Ltd
US$ 0,203
(30,88%)
26,07M
LTRYLottery com Inc
US$ 1,86
(31,91%)
20,13M
CYNCYNGN Inc
US$ 0,0635
(-24,94%)
14,37M
Aucune Discussion Trouvée
Ajouter une Discussion